in a multi-centre , double-blind , cross-over trial comprising 38 patients with rheumatoid arthritis , ketoprofen was given at a dosage of 150 mg daily and phenylbutazone at a dosage of 300 mg daily , each for 2 weeks .
C0003873
rheumatoid arthritis
C0022635
ketoprofen